• ASBrS is pleased to begin our Fall Virtual Education Series of online events. On Thursdays through mid-December, the Society will host engaging events designed to connect members to the latest information on treating patients with breast disease.

  VirtualASBrS—Event Access

  Industry Events

  ---

  The ASBrS 2020 Virtual Education Series is supported through educational grants provided by 3M + KCI, Ambry Genetics, BD/Bard, Elucent Medical, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Invitae, John Wayne Cancer Foundation, Merck & Co., Inc., and TME and marketing support provided by Agendia, Ambry Genetics, Cardinal Health, Endomag, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Kubtec Medical Imaging, Mammotome, Medtronic, Myriad Genetics, Inc., PeerView Institute, and Stryker.

ASBrS COVID-19 Updates

• May 15, 2020

  Updated Recommendations: Consortium Releases Guidance on Multidisciplinary Breast Cancer Care During Pandemic Recovery

  Learn More

  COVID-19 Considerations for Re-entry

  ×

  May 15, 2020

  Dear Colleagues:

  In an effort to rapidly produce guidance for the health care community, a consortium of experts from The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) and the American College of Radiology® (ACR®) joined forces to produce an Executive Summary and then an Editorial to help busy clinicians navigate through difficult decisions during the COVID-19 pandemic.

  We created a follow up document (pdf) to help guide the health care community through the recovery stage of the pandemic, recognizing that different hospitals and cancer centers would be in different phases of the pandemic and recovery. We were delighted to have experts from the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) join the consortium. This document is a combination of peer reviewed literature as well as expert opinion when good data was not available. Since breast cancer is a multidisciplinary disease, we felt the best way to present this was in a multidisciplinary conference fashion. For some of the scenarios, one or another of the disciplines is more prominent.

  Please feel free to use and to distribute this document. We welcome your feedback.

  Jill R. Dietz, MD
  President
  On Behalf of the ASBrS Board of Directors

  Download Paper (PDF)

  Close

  Get PDF

---

• April 13, 2020

  COVID-19 Pandemic Breast Cancer Consortium

  Webinar Recording Now Available—Watch Now!

  Watch Now

  April 13: Webinar Recording

  ×

  The COVID-19 Pandemic Breast Cancer Consortium

  Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic

  Webinar

  Monday, April 13, 7:00–8:00 PM ET

  Description:

  On Monday, April 13, the Society co-hosted a webinar to discuss the recently released Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic (download pdf).

  The panel was comprised of a multidisciplinary group of experts from The American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Cancer Network (NCCN), the Commission on Cancer (CoC) of the American College of Surgeons, and the American College of Radiology (ACR)

  Read Related Press Release

  Close

---

• April 7, 2020

  Updated Recommendations: Treating Breast Cancer Patients During the COVID‑19 Pandemic

  Learn More

  Updated Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID‑19 Pandemic

  ×

  April 7, 2020

  Dear Colleagues:

  Our Society, NAPBC, CoC, NCCN and ACR recently collaborated to produce the manuscript, Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic (download PDF), which was accepted for publication in Breast Cancer Research and Treatment. Please utilize this updated manuscript in place of the executive summary we previously sent to you. We wanted to get the paper to you as soon as possible and will alert you when it is published both online and in print. We hope that this resource helps with some of the difficult decisions that you all are facing.

  Stay healthy and safe during these uncertain times.

  Stay Well,

  Jill R. Dietz, MD
  President
  On Behalf of the ASBrS Board of Directors

  Download Manuscript (PDF)

  Close

  Get PDF

---

• April 1, 2020

  Society Launches COVID-19 Registry

  Visit Page
• Society Releases ASBrS Resource Guide to Endocrine Therapy in the COVID-19 Pandemic

  Get PDF
• Society Launches COVID-19 Resource Center

  Visit Page